Skip to main content
Figure 2 | Respiratory Research

Figure 2

From: Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Figure 2

Change from baseline versus placebo estimated using the full covariate model for selected treatments. A: FEV1; B: rate ratio of moderate/severe exacerbations*; C: Total SGRQ. *Derived from studies in which patients were required to have an explicit exacerbation history at baseline. BUD = budesonide, CI = confidence interval, FEV1 = forced expiratory volume in one second, FF = fluticasone furoate, FORM = formoterol, FP = fluticasone propionate, SAL = salmeterol, SGRQ = St George’s Respiratory Questionnaire, VI = vilanterol.

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us